histamine and kwd 2131

histamine has been researched along with kwd 2131 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegardt, B; Löwhagen, O; Svedmyr, N1
Pegelow, KO; Strandberg, K1
Granerus, G; Hegardt, B; Löwhagen, O; Svedmyr, N1

Trials

3 trial(s) available for histamine and kwd 2131

ArticleYear
Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
    Allergy, 1980, Volume: 35, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Histamine; Humans; Male; Middle Aged; Terbutaline

1980
Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
    Allergy, 1980, Volume: 35, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Allergens; Asthma; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Rate; Histamine; Humans; Hypersensitivity; Male; Peak Expiratory Flow Rate; Random Allocation; Terbutaline; Tremor

1980
The protective property of equipotent bronchodilating doses of inhaled KWD 2131 and terbutaline against allergen-induced bronchospasm.
    Allergy, 1982, Volume: 37, Issue:6

    Topics: Administration, Intranasal; Adult; Allergens; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Female; Forced Expiratory Volume; Histamine; Humans; Male; Terbutaline

1982